By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Intrexon Corporation (San Diego, CA) 

6620 Mesa Ridge Road

San Diego  California  92121  U.S.A.
Phone: n/a Fax: n/a


Founded in 1998, Intrexon Corporation is a privately held biotechnology company focused on the industrial engineering of synthetic biology. Intrexon is deploying its extensive capabilities to rapidly design and produce novel and enhanced biological products and processes across multiple industry sectors, including: human therapeutics, protein production, industrial products, agricultural biotechnology, and animal science. The company’s advanced bioindustrial engineering platform enables Better DNA™ technology by combining breakthroughs in DNA control systems with corresponding advancements in modular transgene design, assembly, and optimization to enable unprecedented control over the function and output of living cells.

Our mission is to redefine the biotechnology development process by engineering complex multigenic biological and cellular systems at unprecedented scale, dramatically reducing the time, cost, and risks associated with synthetic biology. With an extensive and expanding patent portfolio, Intrexon is working with key channel partners throughout our commercial divisions to utilize the industrial engineering of synthetic biology in developing new products and processes, which will alleviate shortages of essential nutrients, bring better medicines to more people, and generate renewable fuels and other resources. Our Better DNA™ technology provides the foundation to industrialize the development of high-performing biological products and enable many new possibilities across broad industries.

Intrexon’s commercial and core technology divisions are located within the country’s major biotechnology hotbeds. In California, San Francisco is the primary site of the Protein Production and Industrial Products Divisions, with our Cell Engineering Unit nearby in San Diego. Intrexon’s expansive Germantown, Maryland facility is centrally located within the Mid-Atlantic biotech region and is currently home to our Human Therapeutics and Animal Science Divisions, as well as our Molecular Engineering Unit. Corporate headquarters, as well as the UltraVector Technology Division are both located in Blacksburg, Virginia. Finally, the southern states host a second site for our Protein Production Division in Charleston, South Carolina, in addition to our Agricultural Biotech Division in Research Triangle Park, North Carolina.

We are always seeking those who share our passion for excellence, hard work, creativity, and moving beyond the limitations of traditional biotech. With Intrexon you will have an exceptional opportunity to join the forefront of the bioindustrial revolution and contribute directly to the future of synthetic biology applications and products.

Please visit for further information on our company.

Key Statistics

Ownership: Private

Web Site: Intrexon Corporation (San Diego, CA)


Company News
Intrexon Corporation Completes Acquisition Of MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) 3/7/2014 9:48:59 AM
Fibrocell Science, Inc. And Intrexon Corporation Expand Collaboration To Include Hypermobility-Type Ehlers-Danlos Syndrome 1/13/2014 11:51:05 AM
Intrexon Corporation Announces A Research And Development Collaboration With Johnson & Johnson (JNJ) Innovation to Advance New Skin And Hair Products 12/30/2013 9:35:03 AM
Intrexon Corporation Prices Initial Public Offering 8/8/2013 6:54:54 AM
AmpliPhi Biosciences (TGEN) Establishes Collaboration With Intrexon Corporation 4/16/2013 9:34:08 AM
Oragenics, Inc. (OGEN)-Intrexon Corporation Collaboration Announces Significant Progress Towards Commercial Production of Lead Lantibiotic MU1140 2/12/2013 9:49:36 AM
Scheer Partners, Inc. Represents Biotech Company Intrexon Corporation in 55,000-Square-Foot Lease of Lab and Office Space in Germantown 10/22/2012 11:00:21 AM
Synthetic Biologics, Inc. (AEN) and Intrexon Corporation Enter Worldwide Exclusive Collaboration for Infectious Diseases 8/8/2012 7:58:04 AM